More than a third of U.S. states have legalized adult-use cannabis, and the Maryland cannabis industry is watching closely for a road map of what to do—and what to do differently—when adult (also known as recreational) cannabis use for people over the age of 21 arrives in the Old Line State. Medical cannabis was legalized in the state in 2014.

In addition to learning from its neighbors—Virginia legalized adult use in 2021 and is in the midst of the regulatory process, while the District of Columbia legalized recreational cannabis for adults over 21 in 2014 but lacks a regulated retail market due to its lack of statehood—Maryland can draw on its own experience during the legalization and regulatory process for medical cannabis.

While legislation forming the Medical Cannabis Commission, tasked with ironing out regulations and awarding licenses, passed in 2014, the first medical dispensaries in the state didn’t open their doors until late 2017. After Maryland’s medical cannabis industry launched to criticism about the lack of diversity among the business owners awarded a limited number of initial licenses, Governor Larry Hogan ordered a diversity study that resulted in making 20 additional licenses available with consideration of racial and ethnic diversity during application approvals.

The Maryland Minority Cannabis Business Association (MMCBA), established in 2021 by veteran lobbyists Michael Arrington, a Democrat and former state delegate, and John Kane, an entrepreneur and former Maryland Republican Party chairman, sees the eventual adult-use cannabis regulatory process as an opportunity for the state to correct disparities in the initial medical cannabis license rollout. Through the association, they hope to advocate for policies that level the playing field.

“I look at it as being a once-in-a-lifetime chance to bring some parity to help fund health care needs and help cities—Baltimore City in particular—where they’ve just been devastated by the so-called ‘War on Drugs,’” Kane says of the equitable distribution of adult-use cannabis licenses. “And if they can reverse some of that, then I think that’s a good thing.”

With a mission to ensure minority business owners interested in entering the cannabis industry have professional representation and advocacy for creating and enforcing sensible and equitable legislative policies, Kane and Arrington studied challenges minority-owned cannabis businesses faced in states where adult use was already legal.

“We asked, ‘What are the three things that are limiting the ability of minorities to be successful?’ Because in all 16 states with an adult use industry at the time, the majority of minority-owned cannabis firms failed,” Kane explains. Through their research, the MMCBA found a lack of advocacy, lack of education about the cannabis business industry, and lack of capital to be the main barriers to success.

When adult-use cannabis comes to Maryland, the MMCBA plans to address these three areas through professional development programming for members and providing connections to potential investors. With the membership funds, Kane and Arrington will lobby for more equitable policies.

“Our targeted member is a husband and wife who own a couple of tire stores and want to get into cannabis, maybe they want to get into retail or into the grow side,” Kane explains. “Members would get to participate in bootcamps—two-to-three-day events bringing in experts on subjects like submitting responses to RFPs for licensing, how to set up the organization from a tax structure, legal and real estate considerations—all the things where, if you get one wrong, it can kill you.”

With access to comprehensive resources and funding, Kane hopes that minority owners granted licenses for the adult use program have the tools they need to succeed.

Members of the local cannabis industry praise the medical program the state has built for its focus on patient education and relatively low barriers to access.

“Maryland has at its core a really great medical program,” says Wendy Bronfein, co-founder, chief brand officer, and director of public policy at Curio Wellness. “It was created with respect for the patient-provider relationship and without a lot of hoop-jumping for participation for patients and providers to get access to this therapeutic product.”

Maryland’s largest medical cannabis brand, Curio Wellness, opened a $7-million, 34,000-square-foot, product-research, development, and manufacturing facility in Cockeysville last year and employs 250 people across its growing, processing, and retail businesses.

Bronfein says that how state regulators balance an eventual adult-use cannabis program while strengthening and sustaining the existing medical cannabis program is critical to the success of both industries.

“We know a lot more today than we did in 2014,” Bronfein says.

“Policy makers need to look at strengthening and improving medical while developing what adult use looks like. If we’ve had five years of a strong medical program and people say they want adult use, let’s not let our fears of a stigmatized product create unnecessary barriers,” she continues. “It’s really common in this industry to have a lot of unnecessary rules that make people feel better about the legalization of something that has been stigmatized for so long and was illegal. It doesn’t make for safer product—it just increases cost.”

In a market with both medical and adult use programs, Bronfein explains, medical cannabis would be differentiated from adult use by remaining untaxed and offering a deeper breadth of products in terms of potency, specialized dosing, and specialized product development. Curio already has two proprietary products, one focusing on sleep and the other on gastrointestinal issues. While each market is unique due to state-specific regulations, Curio will get insight into how its therapeutic products perform in an adult use market through its new dispensary franchise Far & Dotter, which will open its first two out-of-state franchises in Mississippi and New Jersey, the latter of which has a brand-new adult use industry.

“Some of the knowledge we learn in these markets will be transferrable, but some will not because regulations vary by state,” Bronfein says. “But anything that has to do with how you engage with people and what the customer experience feels like is most likely transferrable.”

Additionally, the franchise owners will receive support from the $30-million Curio Wellness Investment Fund, which provides women, minorities, and disabled veterans access to startup capital and operational infrastructure with a three-year path to 100-percent ownership.

The idea to franchise first came up in 2018, just a year into the state’s medical cannabis program, Bronfein says. Curio’s team got to know the pain points for local dispensary owners while selling their wholesale products to 91 of the 93 dispensaries in the state. “As an operator, we saw it’s not as simple to run a dispensary as thinking, ‘I could own and run a retail store,’” she says. “It not only requires a great retailer, but also requires you are highly compliant to a series of regulations that don’t make it easy to do business, plus you have to be a world-class marketer to make your location what a customer is going to choose,” Bronfein explains.

The Curio Wellness Investment Fund is Curio’s response to conversations in the industry around the need for more diverse ownership. Together, Bronfein and the Curio team hope the franchise model and access to capital will provide needed resources to others looking to succeed in medical cannabis.

“It is more important to us to promulgate a brand and customer experience in this industry than to outright own the dispensary and the license,” Bronfein says. “To turn what we’re doing into a toolkit à la a franchise, or business-in-a-box, allows prospective entrepreneurs to step up, follow a playbook, receive a brand and operating toolkit, and become that owner in the dispensary every day leading a team and engaging customers as the face of the brand in the community.”

The potential for growth in both medical and adult-use cannabis programs will have a huge economic impact on the state through tax revenue and job creation.

“Many people get focused on the idea of the opportunity being rooted in the license that one person wins and reaps wealth off of, and obviously that’s a piece of the puzzle, but there are so many jobs and opportunities created through these career paths that can’t be ignored,” Bronfein says. “The medical program has been a massive catalyst for job creation and career development, and adding another layer with adult use creates a really strong economic agent for everyone in Maryland.”

Laura Barrett-Nutting, a registered nurse for more than 25 years who formerly worked for Johns Hopkins Medicine implementing an integrated, electronic medical record-keeping system, is just one example of someone whose career path has pivoted thanks to the state’s medical cannabis program.

“I wasn’t a cannabis user or cannabis advocate at all prior to 2016,” explains Barrett-Nutting, known professionally as “Nurse Laura.” Today, she is president and founder of the National Clinical Directors Consortium, which brings together cannabis clinical directors across the nation, as well as a consultant providing cannabis education and services to individual patients, dispensaries, and health care providers.

She found her way into the space when a friend asked her to serve as the medical advisor to a grow facility he was opening in Howard County. After some time and a lot of research, Barrett-Nutting agreed. Before starting her own business, Barrett-Nutting had experience in all sides of the local cannabis market, from growing and processing to distribution and retail. When consolidation in the medical cannabis industry resulted in Barrett-Nutting leaving the business, she put her skills to use where she saw a need in the market.

Maryland requires every dispensary to have a registered clinical director—a position that can be filled by a nurse, pharmacist, or doctor—available to provide training and education for dispensary staff. Barrett-Nutting established the National Clinical Directors Consortium in 2021 as a resource for clinical directors in Maryland to create reliable standards for patient care, improve dispensary staff education, and continue to advocate to reduce the stigma of cannabis. The group quickly expanded to support practitioners in this role beyond the state.

She points to the leveling out of the medical cannabis market and a surplus of product in Maryland as a challenge as adult-use programs loom over the industry.

Because cannabis use is illegal at the federal level, every product sold in the state must also be grown and processed locally. “In the beginning, we had no plant—we had nothing to sell. It was very hard to get the industry off the ground,” Barrett-Nutting says. “Now we’re in the opposite boat. Now the growers have a surplus. There’s more flower than we have patients to sell it to.

“Prices are coming down a little, but not a lot, because the cost of growing and processing is still high,” she continues. “When we started, we had all these projections going up and up, and now it’s kind of leveling off. You’re not having as many patients sign up.”

As of mid-October, Maryland was just shy of 160,000 registered medical cannabis patients, according to data from the Maryland Medical Cannabis Commission (MMCC)—the state’s largest number to date. But as the market matures, it’s seeing a slower rate of growth over the last six months than the same period in prior years.

Launching an adult use program would reduce some barriers to cannabis use that currently exist with the medical program, including the red tape associated with registering as a patient and regulations preventing medical cannabis patients from buying or possessing a firearm.

However, Barrett-Nutting and some of her peers see challenges in the huge consumer education need that comes along with launching an adult use program.

“A concern is that any requirement for having some type of health care professional support at dispensaries might go away, and that patients, even people who are just shopping in adult use dispensaries, will accidentally get side effects from the things they purchase that are unintended,” she says.

If people aren’t properly educated about dosage, potential interactions with other drugs, and what to expect, she explains, they could get too high and have negative experiences.

In the fall, the MMCC conducted a patient survey to help prepare for public health measures in anticipation of adult use legalization. According to the MMCC, the survey is part of a broader research effort to inform future public health initiatives around cannabis use in the state. The survey assesses data on a variety of topics including product preferences and patterns of use, product efficacy and health outcomes, access and barriers to medical cannabis acquisition and consumption, and additional health and safety measures related to cannabis use and storage.

“The valuable information collected through the patient survey and these additional studies will be indispensable for planning future program and policy efforts to protect and safeguard consumers and the public,” said the MMCC chair Tiffany Randolph in a press release.

With good policies, there’s potential for thriving adult-use and medicinal cannabis programs to coexist, meeting the needs of different types of users.

Benefits to continuing as a medical patient in an adult use market include no or lower tax on the product to shorter lines. Additionally, Barrett-Nutting expects that medical dispensaries would offer a broader range of products.

“If they’re looking for some of the other more minor cannabinoids, the less intoxicating products, those will hopefully still be available in the medical market, whereas the adult use market will more likely have some of the fun and the higher-THC type of products,” she says, noting that the MMCC recently reduced the cost of the administrative fee and extended the card length for medical patients to further reduce barriers to entry. Plus, says Barrett-Nutting, medicinal users would have access to a health care professional for guidance. “For those reasons, it’ll make sense to stay a medical patient.”

RETAIL RESOURCES

Maryland is home to nearly 100 licensed medical cannabis dispensaries helping patients find the best therapeutic product for their needs. (List sourced from the Maryland Medical Cannabis Commission.)

ALLEGANY COUNTY
Allegany Med Marijuana Dispensary
100 Beall St.
Cumberland, MD 21502

Grow West Cannabis Company
1096 W. Industrial Blvd.
Cumberland, MD 21502

ANNE ARUNDEL COUNTY
Gold Leaf
2029 West St.
Annapolis, MD 21401

Green Point Wellness
823-A Elkridge Landing Rd.
Linthicum, MD 21090

Greenlight Therapeutics
782 State Route 3 North, Suite A
Gambrillis, MD 21054

Mana Supply Company
3005 Solomons Island Rd.
Edgewater, MD 21037

Maryland Physician Partners
7609 Energy Parkway, Suite 901
Curtis Bay, MD 21225

Nature’s Medicines
1657 Crofton Blvd.
Crofton, MD 21114

Oceanside Cannabis
16 Magothy Rd.
Pasadena, MD 21122

BALTIMORE CITY

Blair Wellness Center
5806 York Rd.
Baltimore, MD 21212

Charm City Medicus, LLC
717 North Point Blvd.
Baltimore, MD 21224

Culta, LLC
215 Key Highway
Baltimore, MD 21230

Dr. Dots Dispensary
805 N. Howard St.
Baltimore, MD 21201

GreenLabs
1522 Eastern Ave.
Baltimore, MD 21231

Health for Life Baltimore
6807 Rolling Mill Rd.
Baltimore, MD 21224

Maggie’s
3317 Keswick Rd.
Baltimore, MD 21211

Pure Life Wellness
35 E. Cross St., Federal Hill
Baltimore, MD 21230

ReLeaf Shop
1114 Cathedral St., Suite 5
Baltimore, MD 21201

Star Buds
5975 Belair Road
Baltimore, MD 21206

Storehouse
5730 Falls Rd.
Baltimore, MD 21209

BALTIMORE COUNTY
Americana Dispensary
3531 Washington Blvd.,
Suite 112
Baltimore, MD 21227

Blue Ridge Wellness
9413 Harford Rd.
Parkville, MD 21234

The Botanist
7175 Security Blvd., Suite 102
Windsor Mill, MD 21244

Chesacanna
10534 York Rd.
Cockeysville, MD 21030

Chesapeake Health Sciences, LLC
102 Carroll Island Rd.
Baltimore, MD 21220

Curaleaf
11722 Reisterstown Rd.
Reisterstown, MD 21136

Curio Wellness
2060-A York Rd.
Timonium, MD 21093

Ethos Cannabis
6328 Baltimore National Pike
Baltimore, MD 21228

Health for Life White Marsh
4741 Ridge Rd.
Nottingham, MD 21236

Kip
9 Cranbrook Rd.
Cockeysville, MD 21030

The Living Room Company, LLC
1636 Reisterstown Rd.
Pikesville, MD 21208

Mana Middle River
100 Carroll Island Rd.
Middle River, MD 21220

Mission Catonsville
6328 Baltimore National Pike
Catonsville, MD 21228

Nirvana Center
5225 Baltimore National Pike
Baltimore, MD 21229

Oceans Dispensary
100 Carroll Island Rd.
Middle River, MD 21220

Temescal Wellness of MD LLC
1636 Reisterstown Rd.
Pikesville, MD 21208

Your Farmacy
1526 York Rd.
Lutherville, MD 21093

ZenLeaf
101 E. Chesapeake Ave.,
Suite 102
Towson, MD 21286

CALVERT COUNTY
Greenwave Maryland
10 Creston Ln., Ste 2
Solomons, MD 20688

CARROLL COUNTY
The Dispensary
330140 Village Rd.
Westminster, MD 21157

Herbology
700-K Corporate Center Ct.
Westminster, MD 21157

Verilife
700 Corporate Center Ct., Suite K
Westminster, MD 21157

CECIL COUNTY
Nature’s Care & Wellness
4925 Pulaski Hwy., Suite A
Perryville, MD 21903

PharmKent
330 East Pulaski Hwy., Suite B
Elkton, MD 21921

CHARLES COUNTY
Chesapeake Apothecary
4781 Crain Hwy., Suite A
White Plains, MD 20695

Dispensary Works
10766 DeMarr Rd., Suite 3A
White Plains, MD 20695

Zen Leaf Waldorf
2290 Old Washington Rd.,
Ste 12383
Waldorf, MD 20601

DORCHESTER COUNTY
Sunburst Pharm
603 Meteor Dr.
Cambridge, MD 21613

FREDERICK COUNTY
Euphoria Wellness
11717 Old National Pike
New Market, MD 21774

gLeaf Medical Cannabis
4606 Wedgewood Blvd.
Frederick, MD 21703

Green Goods
1080 West Patrick St.
Frederick, MD 21703

Kannavis
8709 Fingerboard Rd.
Frederick, MD 21702

Sweetbuds Dispensary
5312 New Design Rd.
Frederick, MD 21703

Wellness Institute of Maryland
4606 Wedgewood Blvd.
Frederick, MD 21703

HARFORD COUNTY
Four Green Fields, LLC
3518 Conowingo Rd.
Street, MD 21154

Rev Canna
3111 Emmorton Rd.
Abingdon, MD 21009

Rise-Joppa
702 Pulaski Hwy.
Joppa, MD 21085

True Wellness Aberdeen
226 S. Philadelphia Ave.
Aberdeen, MD 21061

HOWARD COUNTY
Green Point Wellness
116 Washington Blvd. South
Laurel, MD 20707

Greenhouse Wellness
4801 Dorsey Hall Dr., Suite 110
Ellicott City, MD 21042

Nature’s Medicines
10169 Baltimore National Pike
Ellicott City, MD 21042

Remedy
6656-E Dobbin Rd.
Columbia, MD 21045

Revolution ReLeaf
9994 Washington Blvd. North
Laurel, MD 20723

Trilogy
9291 Baltimore National Pike
Ellicott City, MD 21042

Zen Leaf
7221 Montevideo Rd., Suite 150
Jessup, MD 20794

MONTGOMERY COUNTY
Bloom Medicinals
11530 Middlebrook Rd.
Germantown, MD 20876

Columbia Care
4609 Willow Lane
Chevy Chase, MD 20815

Curaleaf Gaithersburg
10011 Stedwick Rd.
Gaithersburg, MD 20886

Elevate Takoma
6309A New Hampshire Ave.
Takoma Park, MD 20912

Ethos Cannabis
4007 Norbeck Rd., Unit A
Rockville, MD 20853

Grassroots
106 N. Frederick Ave.
Gaithersburg, MD 20877

gLeaf Medical Cannabis
808 Hungerford Dr.
Rockville, MD 20850

Harvest
12200-B Rockville Pike
Rockville, MD 20852

Health For Life Bethesda
4909 Fairmont Ave.
Bethesda, MD 20814

Herbafi
8413 Ramsey Ave.
Silver Spring, MD 20910

Herbiculture
4009 Sandy Springs Rd.,
Unit 101
Burtonsville, MD 20866

Liberty
12001 Nebel St.
Rockville, MD 20852

MI Health
8355 Snouffer School Rd.
Gaithersburg, MD 20879

Peake ReLeaf
2001 Chapman Ave.
Rockville, MD 20852

Potomac Holistics
14808 Physicians Ln., Suite 212
Rockville, MD 20850

Rise Bethesda
10401 Old Georgetown Rd.,
Suite 210
Bethesda, MD 20814

Rise Silver Spring
7900 Fenton St.
Silver Spring, MD 20910

Sweetspot
18070 Georgia Ave.
Olney, MD 20832

Verilife
5544 Nicholson Ln.
Rockville, MD 20852

Zenity Wellness
811 Russell Ave., Suite C
Gaithersburg, MD 20878

Zen Leaf Germantown
13007 Wisteria Dr.
Germantown, MD 20874

PRINCE GEORGE’S COUNTY
Altpharm
4710 Auth Place, Suite 595
Suitland, MD 20746

Haven
7501 Clymer Dr.
Brandywine, MD 20619

JOVA Wellness Center
5846 Allentown Way
Camp Springs, MD 20748

Mary and Main
8801 Hampton Mall Drive N.
Capital Heights, MD 20743

Medleaf
9520 Marlboro Pike,
Unit 103 & 104
Upper Marlboro, MD 20772

Salvera
4201 Northview Dr., Suite 100
Bowie, MD 20716

True Wellness Laurel
14703 Baltimore Ave., Suite B
Laurel, MD 20707

Waave Cannabis
7327 Hanover Ct., Suite A
Greenbelt, MD 20770

QUEEN ANNE’S COUNTY
Ash + Ember
202 Coursevall Dr., Suite 108
Centreville, MD 21617

ST. MARY’S COUNTY
Southern Maryland Relief
28105 Three Notch Rd.
Mechanicsville, MD 20659

WASHINGTON COUNTY
Maryland Heath & Wellness Center, Inc.
1571 Wesel Blvd.
Hagerstown, MD 21740

WICOMICO COUNTY
Peninsula Alternative Health
400 Snow Hill Rd.
Salisbury, MD 21804

WORCESTER COUNTY
Hi-Tide
12600 Marjan Ln., Unit 100
Ocean City, MD 21842

OC Botanicals, LLC
12600 Marjan Ln., Unit 100
Ocean City, MD 21842

Positive Energy
9939 Jerry Mack Rd., Suite 500
Ocean City, MD 21842

As if it were yesterday, Shannon Moore remembers the moment two years ago when a neurologist asked her and her husband, Louis Deliyannis, if they wanted hospice care for their identical twin boys, who were then 3 years old. The boys, Nicolas and Byron, were born with Miller-Dieker syndrome, which causes them to have severe seizures all day, every day.

“When the neurologist said it was time to choose between length and quality of life, we considered medical cannabis,” says Moore, 42. “I knew other parents had successfully used it to treat their children’s seizures.”

But since it wasn’t available in Maryland, they had to use legal hemp oil instead, giving it to the boys through their feeding tubes. It was a stopgap measure, since it has some of the therapeutic qualities that cannabis does. Nevertheless, within days, the frequency and severity of the twins’ seizures decreased by more than half.

“I believe it saved their lives,” says Moore of her boys. “And because it did, I became very driven to make sure that others could be treated with cannabis, which will give us more options.”

In the very near future, those new treatment options will be available to patients like Nicolas and Byron when the state rolls out its medical cannabis program.

But it’s not the panacea it might seem for patients like Moore’s boys: The implications of the new legislation are complicated and imperfect because of discrepancies in federal and state laws—and because of widespread misconceptions about the medical variety of marijuana.

Maryland’s not exactly leading the charge in legalizing medical marijuana. The first time sanctioning cannabis was suggested in Maryland was 1979, but it took years for the cultural zeitgeist to get to a point where the state legislature was ready to join the 18 states (plus the District of Columbia) that have legalized medical marijuana since 2013. That same year, Maryland made cannabis available to teaching hospitals, though none participated. But public opinion backed yet more change: A spring 2014 Goucher College poll showed that 90 percent of Marylanders support the use of the drug for medical purposes, and more legislation passed with bipartisan support last summer.

“Medical cannabis got caught up in the epic war on drugs,” says Del. Dan Morhaim of the 11th District in Baltimore County, an emergency-medicine physician who sponsored the initial bill. “What I’m saying is, let’s remove the sick and the dying from the battlefield.”

The complicated part of the new law is that medical cannabis is not approved by the Food and Drug Administration and the federal government still classifies marijuana as a Schedule I drug, the classification reserved for the most dangerous drugs, including heroin.

As a work-around, the U.S. Department of Justice has told federal prosecutors they can’t go after patients and doctors in states where medical cannabis is legal.

That, of course, leaves a lot of a weird middle ground. Doctors can’t be prosecuted for giving you a recommendation for marijuana to alleviate your multiple sclerosis, for example, but you can still get fired from your job if you come up positive in a drug test.

“Medical cannabis got caught up in the epic war on drugs. Let’s remove the sick from the battlefield.”

Hannah Byron, the outgoing executive director of the Maryland Medical Cannabis Commission (MMCC)—of which Shannon Moore is a member—says that other states are looking at Maryland as a model for their own laws. Among the Maryland law’s stipulations, for instance, are quality controls to make sure medical cannabis is free of substances such as mold, which can be life-threatening to the immune-suppressed.

Byron, a former administrator at the Department of Business and Economic Development, says anyone who is concerned that Maryland is suddenly going to look like Amsterdam on a holiday weekend doesn’t understand what medical cannabis is—and isn’t.

“The way the medicine can be given includes tinctures, oils, patches, suppositories—people want to see alternatives to smoking,” says Byron. She notes that different strains of the plant serve different purposes. The medication for seizures, for example, is low in tetrahydrocannabinol, or THC, marijuana’s active ingredient and the part of the plant that makes you high.

Byron abhors when people use slang like “pot,” and is no-nonsense about the measures the MMCC—which has 16 voluntary members including a police chief, lawyers, a horticulturalist, and doctors—will follow in registering patients and doctors as well as managing licensing, community education, and data reporting. She notes that there are extreme penalties (a $10,000 fine) for diverting medical cannabis. And honestly, if you just want to get high, there are easier ways.

“If someone is really interested in using cannabis for recreational purposes, they’re not going to go through everything you need to go through to get medical cannabis,” says Byron.

Cannabis will have an economic impact. In 2014, Arizona’s medical cannabis market was worth an estimated $155 million, with those numbers in 2015 projected to reach $207 million. Maryland could experience something similar.

“We’re building an entire, homegrown industry that encompasses agriculture, manufacturing, and retail,” Byron says.

Unsurprisingly, entrepreneurs have already jumped into the game to get their slice of the economic trickle-down. Green Leaf Medical, a prospective grower and processor based in Gaithersburg, leased 42,000 square feet of warehouse space last year where it hopes to grow at least 5,000 plants. The company CEO, Philip Goldberg, a local businessman, says Green Leaf’s climate-controlled operation can bring in three or four harvests a year, with each plant providing at least half a pound of dry cannabis. Ambitious local teenagers can abandon hope of getting inside, though. Goldberg says the walls are tilt-up concrete and security includes more than 140 cameras.

“It takes 24 hours to get a guest pass so we can vet you, and, without a badge, you aren’t getting inside,” he says. “We don’t sell retail, so it would be suspicious for anyone to be there. You wouldn’t make it past the gate.”

Proponents point out that cannabis has proven helpful to many, from cancer patients and people with conditions such as rheumatoid arthritis to those with epilepsy. It’s also used for the palliative care of those in hospice. Critics of medical cannabis say there’s not enough research showing its efficacy in disease treatment. And they’re both right.

Because of its classification as a Schedule I drug, research into cannabis has been somewhat restricted. Advocacy groups such as the Epilepsy Foundation are actively working to reclassify marijuana so more studies can be done.

“Of course, there are risks and side effects as we see with many drugs we currently prescribe,” says Morhaim. But marijuana overdose deaths are extremely rare: A recent study claimed to have identified two such cases. In addition, legal medical cannabis could help reduce overdoses using other drugs: The Journal of the American Medical Association reported in 2014 that states with medical cannabis laws saw a 25 percent drop in opioid overdose deaths compared to states where cannabis is still illegal. Such a drop would be good news in Maryland, where the painkiller fentanyl was implicated in 185 deaths in 2014 alone, more than three times as many as the year before.

That’s why Shannon Moore can’t wait to try cannabis instead of the drugs she’s been using as a rescue medication to stop her twins’ extreme seizures. The cannabis is said to help control such episodes without the risks posed by Benzodiazepines (BZD) opioids, which can be addictive and cause respiratory depression.

“I used to think medical cannabis was a joke,” says Moore. “Now, I feel very grateful for it, and I want to make sure others can work through their doctors and have safe access to it as medicine.”